Human inherited PD-L1 deficiency is clinically and immunologically less severe than PD-1 deficiency.
Matthew B JohnsonMasato OgishiClara Domingo-VilaElisa De FrancoMatthew N WakelingZineb ImaneBrittany ResnickEvangelia WilliamsRui Pedro GalaoRichard C CaswellJames Russ-SilsbyYoann SeeleuthnerDarawan RinchaiIris FagniezBasilin BensonMatthew J DufortCate SpeakeMegan E SmithmyerMichelle HudsonRebecca Dobbsnull nullZoe QuandtAndrew T HattersleyPeng ZhangStéphanie Boisson-DupuisMark S AndersonJean Laurent CasanovaTimothy I M TreeRichard D OramPublished in: The Journal of experimental medicine (2024)
We previously reported two siblings with inherited PD-1 deficiency who died from autoimmune pneumonitis at 3 and 11 years of age after developing other autoimmune manifestations, including type 1 diabetes (T1D). We report here two siblings, aged 10 and 11 years, with neonatal-onset T1D (diagnosed at the ages of 1 day and 7 wk), who are homozygous for a splice-site variant of CD274 (encoding PD-L1). This variant results in the exclusive expression of an alternative, loss-of-function PD-L1 protein isoform in overexpression experiments and in the patients' primary leukocytes. Surprisingly, cytometric immunophenotyping and single-cell RNA sequencing analysis on blood leukocytes showed largely normal development and transcriptional profiles across lymphoid and myeloid subsets in the PD-L1-deficient siblings, contrasting with the extensive dysregulation of both lymphoid and myeloid leukocyte compartments in PD-1 deficiency. Our findings suggest that PD-1 and PD-L1 are essential for preventing early-onset T1D but that, unlike PD-1 deficiency, PD-L1 deficiency does not lead to fatal autoimmunity with extensive leukocytic dysregulation.
Keyphrases
- early onset
- single cell
- type diabetes
- replacement therapy
- peripheral blood
- multiple sclerosis
- intellectual disability
- late onset
- end stage renal disease
- acute myeloid leukemia
- ejection fraction
- newly diagnosed
- cell proliferation
- cardiovascular disease
- poor prognosis
- rheumatoid arthritis
- small molecule
- peritoneal dialysis
- immune response
- metabolic syndrome
- interstitial lung disease
- smoking cessation
- weight loss
- protein protein
- patient reported outcomes
- heat shock
- celiac disease